Literature DB >> 4744051

Therapy of sarcoidosis initiated with alternate-day prednisone.

J N Sheagren, H B Simon, R R Rich.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4744051      PMCID: PMC2609208     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  7 in total

1.  STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN.

Authors:  J G HARTER; W J REDDY; G W THORN
Journal:  N Engl J Med       Date:  1963-09-19       Impact factor: 91.245

2.  ALTERNATE-DAY STEROID THERAPY FOR NEPHROTIC CHILDREN.

Authors:  L F SOYKA; K M SAXENA
Journal:  JAMA       Date:  1965-04-19       Impact factor: 56.272

3.  [Intermittent steroid therapy in bronchial asthma. Preliminary report].

Authors:  H N HAUGEN; W J REDDY; J G HARTER
Journal:  Nord Med       Date:  1960-01-07

4.  Alternate-day corticosteroid therapy.

Authors:  G H REICHLING; A M KLIGMAN
Journal:  Arch Dermatol       Date:  1961-06

5.  Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.

Authors:  R R MacGregor; J N Sheagren; M B Lipsett; S M Wolff
Journal:  N Engl J Med       Date:  1969-06-26       Impact factor: 91.245

6.  The treatment of sarcoidosis.

Authors:  H L Israel
Journal:  Postgrad Med J       Date:  1970-08       Impact factor: 2.401

7.  Sarcoidosis: clinical features and management.

Authors:  L E Siltzbach
Journal:  Med Clin North Am       Date:  1967-03       Impact factor: 5.456

  7 in total
  3 in total

1.  Sarcoidosis: a comparison of cutaneous manifestations with chest radiographic changes.

Authors:  B Caruthers; T B Day; H R Minus; R C Young
Journal:  J Natl Med Assoc       Date:  1975-09       Impact factor: 1.798

Review 2.  Primary care paradigm for management of sarcoidosis, Part 1.

Authors:  R C Young; R E Rachal; B Nelson-Knuckles; C N Arthur; H V Nevels
Journal:  J Natl Med Assoc       Date:  1997-03       Impact factor: 1.798

3.  When should sarcoidosis be treated?

Authors:  R C Young; R E Rachal; C L Cowan
Journal:  J Natl Med Assoc       Date:  1986-09       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.